- 专利标题： PHARMACEUTICAL DOSAGE FORMS CONTAINING TASK-1 AND TASK-3 CHANNEL INHIBITORS, AND THE USE OF SAME IN BREATHING DISORDER THERAPY
-
申请号： US16472116申请日： 2017-12-13
-
公开(公告)号： US20200093737A1公开(公告)日： 2020-03-26
- 发明人: Johanna ANLAHR , Moritz BECK-BROICHSITTER , Janine NICOLAI , Martina DELBECK , Michael HAHN , Udo ALBUS , Doris GEHRING , Björn ROSENSTEIN
- 申请人： Bayer Pharma Aktiengesellschaft
- 申请人地址： DE Berlin
- 专利权人： Bayer Pharma Aktiengesellschaft
- 当前专利权人： Bayer Pharma Aktiengesellschaft
- 当前专利权人地址： DE Berlin
- 优先权： EP16205688.1 20161221; EP17157805.7 20170224
- 国际申请： PCT/EP2017/082542 WO 20171213
- 主分类号： A61K9/00
- IPC分类号： A61K9/00 ; A61K47/10 ; A61K31/496
摘要：
The invention relates to new pharmaceutical dosage forms containing potent and selective TASK-1 and/or TASK-3 channel inhibitors, and the use of same to treat and/or prevent breathing disorders including sleep-related breathing disorders such as obstructive and central sleep apnea and snoring.
信息查询
